Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$13,536,045
+$179,819 QoQ
Shares Held
37,380
-1.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
8.66%
of 13F equity value
Holder Rank
#455
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Round Hill Asset Management holds $42,939,237 across 7 Drug Manufacturers - General names. AMGN ranks #1 (31.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
This page
|
37,380 | $13,536,045 | |
| 2 | MRK |
Merck & Co., Inc.
|
71,350 | $9,168,475 | |
| 3 | NVO |
Novo Nordisk A S
|
122,031 | $5,850,166 | |
| 4 | PFE |
Pfizer Inc
|
242,134 | $5,830,586 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
71,646 | $4,128,242 | |
| 6 | ABBV |
AbbVie Inc.
|
15,475 | $3,894,129 | |
| 7 | NVS |
Novartis AG
|
3,392 | $531,594 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,536,045 | 37,380 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $13,356,226 | 37,960 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $13,437,712 | 41,055 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $11,935,084 | 42,293 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $11,817,004 | 42,323 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $13,475,472 | 43,253 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $11,663,118 | 44,748 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $14,280,024 | 44,319 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $15,016,347 | 48,060 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $14,141,223 | 49,737 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $14,583,028 | 50,632 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $13,915,586 | 51,777 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,793,036 | 53,117 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,969,645 | 53,649 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $14,507,970 | 55,239 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $12,618,568 | 55,983 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,675,163 | 56,207 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $13,633,327 | 56,378 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $12,642,864 | 56,198 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $11,969,643 | 56,288 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,846,950 | 56,808 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $14,161,767 | 56,918 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $13,109,808 | 57,019 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $14,527,531 | 57,159 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $13,632,472 | 57,799 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $12,070,341 | 59,539 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||